<code id='34008ED379'></code><style id='34008ED379'></style>
    • <acronym id='34008ED379'></acronym>
      <center id='34008ED379'><center id='34008ED379'><tfoot id='34008ED379'></tfoot></center><abbr id='34008ED379'><dir id='34008ED379'><tfoot id='34008ED379'></tfoot><noframes id='34008ED379'>

    • <optgroup id='34008ED379'><strike id='34008ED379'><sup id='34008ED379'></sup></strike><code id='34008ED379'></code></optgroup>
        1. <b id='34008ED379'><label id='34008ED379'><select id='34008ED379'><dt id='34008ED379'><span id='34008ED379'></span></dt></select></label></b><u id='34008ED379'></u>
          <i id='34008ED379'><strike id='34008ED379'><tt id='34008ED379'><pre id='34008ED379'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:241
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Longer MASH drug regimen improved liver, Akero study finds

          AdobeAkeroTherapeuticssaidMondaythatextendingtreatmentwithitsexperimentaldrugfortheliverdiseaseknown